Evidence map›Paper›PMID 39063556›Full record

ArticleLife (Basel, Switzerland)2024

Contribution of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 to Upper Tract Urothelial Cancer Risk in Taiwan.

Bo-Ren Wang, Hung-Huan Ma, Chao-Hsiang Chang, Cheng-Hsi Liao, Wen-Shin Chang, Mei-Chin Mong, Ya-Chen Yang, Jian Gu, Da-Tian Bau, Chia-Wen Tsai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Genetic Variations inCancers · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bo-Ren WangGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.
Hung-Huan MaDivision of Nephrology, Department of Internal Medicine, Taichung Tzu Chi Hospital, Taichung 427003, Taiwan.
Chao-Hsiang ChangTerry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung 404327, Taiwan.
Cheng-Hsi LiaoGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.
Wen-Shin ChangGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.
Mei-Chin MongDepartment of Food Nutrition and Health Biotechnology, Asia University, Taichung 413305, Taiwan.ORCID 0000-0001-7051-2464
Ya-Chen YangDepartment of Food Nutrition and Health Biotechnology, Asia University, Taichung 413305, Taiwan.
Jian GuDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0003-3499-0973
Da-Tian BauGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.
Chia-Wen TsaiGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Matrix metalloproteinase (MMP)-2 and -9, which degrade type IV collagen, are linked to cancer invasion and metastasis. Gene polymorphisms in

Indexed as

genotypeMMP-2MMP-9phenotypepolymorphismupper tract urothelial cancer

Identifiers

PMID39063556
PMCPMC11277778

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.